Additionally, serum Fibroblast Growth Factor (FGF) 21 levels were found to positively correlate with post-DST cortisol, cortisol-to-ACTH ratio, and tumor size, suggesting a potential role for FGF21 as a biomarker of the cortisol secretion severity [107]. Here, FGF21 is linked to neoplasm.